DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» YES1
YES1
YES1 Amplification Is a Mechanism of Acquired Resistance to EGFR Inhibitors Identified by Transposon Mutagenesis and Clinical Genomics
Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia
Anti-Yes1 Picoband Antibody Catalog # ABO12155
Personalized Prediction of Acquired Resistance to EGFR-Targeted Inhibitors Using a Pathway-Based Machine Learning Approach
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
Identification of the YES1 Kinase As a Therapeutic Target in Basal-Like
SUPPLEMENTAL TABLE 1. Mass Spectrometry on EGFRL858R/T790M Protein
Myeloid Innate Immunity Mouse Vapril2018
A Phosphotyrosine Switch Regulates Organic Cation Transporters
4059.Full.Pdf
Systemic Analysis of Tyrosine Kinase Signaling Reveals a Common Adaptive Response Program in a HER2-Positive Breast Cancer
Downloads.Action)
I Role of ABL Family Kinases in Breast Cancer by Jun Wang
Supplementary Information Supplementary Table 1
Targeting the Hsp90-Cdc37-Client Protein Interaction to Disrupt Hsp90 Chaperone Machinery Ting Li1, Hu-Lin Jiang2, Yun-Guang Tong3,4 and Jin-Jian Lu1*
YES1, Active YES1, Active
YES1 Amplification Is a Mechanism of Acquired Resistance to EGFR Inhibitors Identified by Transposon Mutagenesis and Clinical Genomics
Tyrosine Kinase Panel
Top View
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
Identification of Potent Yes1 Kinase Inhibitors Using a Library
Nanostring®: Product Data Sheet | Ncounter® GX Human Kinase
Chemical Proteomics Reveals Target Selectivity of Clinical Jak Inhibitors in Human Primary Cells Received: 18 April 2019 H
Table S1. List of Potential Positive and Negative Regulators of Telomerase
High Throughput Kinase Discovery, Inhibitor Screening and Specificity Analysis Using Multi-Array Technology
Yes Antibody (R31908)
Supplementary Data
Antineoplastic Kinase Inhibitors: a New Class of Potent Anti-Amoebic Compounds
YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification
Global Target Profile of the Kinase Inhibitor Bosutinib in Primary
INKA, an Integrative Data Analysis Pipeline for Phosphoproteomic Inference of Active Kinases
JAK2 Inhibitor: in Vitro Assessment of Kinase Selectivity and Preclinical Studies Using Cell Lines and Primary Cells from Polycythemia Vera Patients
Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk
Exploring Structure and Plasticity of Tyrosine Kinase Domains for Drug Discovery
YES1 Amplification: a Mechanism of Acquired Resistance to EGFR Inhibitors Identified by Transposon Mutagenesis and Clinical Genomics
Highfat Diet in a Mouse Insulinresistant Model Induces
Bcatc Modulates Crosstalk Between the PI3K/Akt and the Ras/ERK Pathway Regulating Proliferation in Triple Negative Breast Cancer